Related Experiment Video

Updated: May 11, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

Propagation of error in ocular pharmacokinetic parameters estimate of azithromycin in rabbits

Linjun You1, Jie Qian, Xiabing Wu

  • 1Department of Analytical Chemistry, China Pharmaceutical University, Nanjing, China.

Journal of Pharmaceutical Sciences
|May 8, 2013
PubMed

Insights

This study introduces a new method to calculate standard deviations for pharmacokinetic parameters from destructive sampling in rabbit eye tissues. This approach enables more accurate comparisons of drug formulations, like azithromycin.

Area of Science:

  • Ocular pharmacology
  • Pharmacokinetics
  • Biostatistics

Background:

  • Ocular drug delivery presents unique challenges for pharmacokinetic analysis.
  • Destructive sampling methods, common in ocular tissue studies, limit the ability to determine standard deviations for pharmacokinetic parameters.
  • Accurate pharmacokinetic parameter error estimation is crucial for drug formulation comparisons.

Purpose of the Study:

  • To develop and validate formulas for estimating pharmacokinetic parameter errors in destructive sampling.
  • To calculate standard deviations for ocular pharmacokinetic parameters of azithromycin in rabbit eye tissues.
  • To propose a novel method for comparing pharmacokinetic behavior using destructive sampling.

Main Methods:

  • Evaluation of azithromycin ocular pharmacokinetics in rabbit eye tissues after single and multiple doses.
  • Development of formulas to estimate pharmacokinetic parameter errors with destructive sampling.
  • Calculation of standard deviations using proposed formulas and analysis of average concentration-time curves.
  • Application of F-test and independent-samples t-test for formulation comparisons.

Main Results:

  • Formulas were detailed for estimating major pharmacokinetic parameter errors in destructive sampling.
  • Standard deviations for pharmacokinetic parameters were calculated using the proposed method.
  • A case study demonstrated the application of the formulas for comparing test and reference formulations.
  • The proposed method allows for statistical comparison of pharmacokinetic behaviors.

Conclusions:

  • A new, simple method was developed to estimate pharmacokinetic parameter errors and their standard deviations in destructive sampling.
  • This method facilitates robust statistical comparisons of drug formulations in ocular studies.
  • The approach has potential applications beyond ocular pharmacokinetics, aiding in various research involving destructive sampling.

More Related Videos

Obtaining High-Quality Cryosections of Whole Rabbit Eye05:59

Obtaining High-Quality Cryosections of Whole Rabbit Eye

Published on: November 10, 2023

A Surgical Approach for Optic Nerve Crush in a Rabbit Model06:15

A Surgical Approach for Optic Nerve Crush in a Rabbit Model

Published on: July 8, 2025

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...